Lee Arcement is a Cardiology physician affiliated with Leonard J. Chabert Medical Center. OpenAlex indexes 56 publications with 442 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1990 Industrial Blvd
Houma, LA 703637055
Telephone
985-868-9300Registry record last updated 15 Oct 2012.
Clinical trials
- Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population
Sponsor: Pennington Biomedical Research Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20252 payments
- Kestra Medical Technology Services, Inc.Program year20251 payment
- E.R. Squibb & Sons, L.L.C.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
89.2%Statin17.1%Atorvastatin Calcium75%Rosuvastatin Calcium15%Pravastatin Sodium9%Lovastatin2%Part D<11 patientsBeta blocker15.8%Carvedilol69%Metoprolol Succinate18%Metoprolol Tartrate12%Atenolol1%Part D<11 patients+ 18 more classes in this area
Blood & clotting
7.2%Factor Xa inhibitor3.3%Eliquis60%Xarelto40%Part D≥43 patientsP2Y12 inhibitor2.6%Clopidogrel100%Part D≥65 patients+ 2 more classes in this area
Metabolism & gastrointestinal
3%SGLT2 inhibitor2.8%Jardiance87%Farxiga13%Part D<11 patientsPotassium supplement0.1%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Heart Failure with Preserved Ejection Fraction: Challenges in Treatment and Palliation (TH326)
Journal of Pain and Symptom Management
2014 - Prevalence of Conduction Abnormalities in a Systolic Heart Failure Population by Race, Ethnicity, and Gender
Annals of Noninvasive Electrocardiology
2012 - Open Access to an Outpatient Intravenous Diuresis Program in a Systolic Heart Failure Disease Management Program
Congestive Heart Failure
2011 - Feasibility of a Heart Failure Disease Management Program in Eastern Europe: Tbilisi, Georgia
Circulation Heart Failure
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”